Pentraxin 3 as a Prognostic Biomarker in Aneurysmal Subarachnoid Hemorrhage
Medical Science Monitor · 2025
DOI: 10.12659/msm.947133 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Science Monitor, 2025. Verfasst von Dong-Liang Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Peking University People's Hospital, Beijing, China. Hauptthemen laut MEDLINE: Serum Amyloid P-Component, C-Reactive Protein, Subarachnoid Hemorrhage. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Peking University People's Hospital, Beijing, China.
Zitieren
APA
Wang, D. L., Jiao, F., Jiang, Y. L., Song, H. D., Li, B., Gao, Q., Wang, B., Hei, B., & Zhou, J. R. (2025). Pentraxin 3 as a Prognostic Biomarker in Aneurysmal Subarachnoid Hemorrhage. Medical Science Monitor. https://doi.org/10.12659/msm.947133
Vancouver
Wang DL, Jiao F, Jiang YL, Song HD, Li B, Gao Q, et al. Pentraxin 3 as a Prognostic Biomarker in Aneurysmal Subarachnoid Hemorrhage. Medical Science Monitor. 2025. doi:10.12659/msm.947133
BibTeX
@article{Wang2025,
author = {Wang, Dong-Liang and Jiao, Feng and Jiang, Yi-Lin and Song, Hai-Dong and Li, Bin and Gao, Qun and Wang, Bin and Hei, Bo and Zhou, Jing-Ru},
title = {Pentraxin 3 as a Prognostic Biomarker in Aneurysmal Subarachnoid Hemorrhage},
journal = {Medical Science Monitor},
year = {2025},
doi = {10.12659/msm.947133}
}
EUVIMED